It has backed more than 150 companies - some of which, like Alnylam Pharmaceuticals, Bluebird bio and Sage Therapeutics, now have drugs either on the market or nearing regulatory approval. The firm seeks to invest in the healthcare. Several ARCH-backed companies have also debuted on public markets in recent quarters, including drug developer EQRx, cancer therapy developer Lyell Immunopharma, and genetic medicines company Verve Therapeutics.ĪRCH was also a key investor in Seattle’s Juno Therapeutics, which was acquired by Celgene in 2018 in a deal worth more than US$9 billion.įounded in 1986, Arch has grown to be one of the most prolific venture firms in technology and the life sciences. Founded in 1986, ARCH Venture Partners is a venture capital investment firm based in Chicago, Illinois. The firm is a recognized leader in commercializing technologies developed at academic institutions, corporate research groups and national laboratories. Arch Real Estate Holdings is injecting capital in Puerto Rico to revitalize, make rental housing available and affordable while improving quality of life. We are raising money and investing in companies around the world from startup seed to growth. ARCH Venture Partners invests in life science and advanced technology companies and is one of the world's leading early-stage venture firms. Arch Capital Partners is a private equity/venture capital fund. Its early- and later-stage rounds tend to be on the large side by venture standards, typically in the tens of millions and often exceeding US$100 million. ARCH VENTURE PARTNERS Profile and History. With Verily vet on board, Mindstrong Health gets 14M to quantify mental health by monitoring smartphone usage. The firm is commonly a lead investor, but also co-invests with other VCs, particularly in larger rounds. Other big lead rounds this year include a US$167 million Series C for mRNA-focused Nutcracker Therapeutics, and a US$76 million Series A for immunotherapy developer Pheast Therapeutics.ĪRCH invests primarily in companies it co-founds with scientists and entrepreneurs. Earlier this month, the firm co-led an US$85 million Series C round for Vizgen, a startup focused on single-cell spatial genomics. This list of organizations invested in by ARCH Venture Partners provides data on their funding history, investment activities, and acquisition trends. The firm seeks to invest in the healthcare, information technology, and commercial services sectors. The firm prefers to invest in seed-stage, early-stage, and later-stage companies. The startup analyzes neurological data to inform its drug research. Founded in 1986, ARCH Venture Partners is a venture capital firm based in Chicago, Illinois. Neumora Therapeutics unveiled 500 million in capital and a research partnership with Amgen. So far this year, ARCH has made 11 disclosed investments, per Crunchbase data. ARCH is an early-stage venture firm that focuses on life science discoveries to prevent, detect, and cure disease. ARCH Venture Partners General Information.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |